Le Lézard
Classified in: Health, Science and technology
Subject: SHA

Chief Executive Officer, Jeff Borcherding, buys Immunovia shares


LUND, Sweden, June 9, 2023 /PRNewswire/ -- Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670 KSEK.

His total holding now amounts to 350 000 shares and 100 000 warrants in Immunovia. 

About Immunovia

Immunovia is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for patients with cancer. 

Our first product, IMMraytm PanCan-d is the only blood test currently available specifically for the early detection of pancreatic cancer. The test has unmatched clinical performance. Commercialization of IMMraytm PanCan-d started in August 2021 in the USA and IMMraytm PanCan-d is offered as a laboratory developed test (LDT) exclusively through Immunovia, Inc. For more information see:?www.immunoviainc.com. 

Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups globally to make this test available to all high-risk pancreatic cancer groups.? 

The USA, the first market in which IMMraytm PanCan-d is commercially available, is the world's largest market for the detection of pancreatic cancer with an estimated, addressable market size of 1.8 million individuals per year who could benefit from our test. Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit?www.immunovia.com 

For more information, please contact:
Karin Almqvist Liwendahl
CFO
[email protected]
+46 70 911 56 08

The following files are available for download:

https://mb.cision.com/Main/13121/3783805/2117015.pdf

Press release (PDF)

 

SOURCE Immunovia AB


These press releases may also interest you

at 17:05
California Attorney General's Office and Osteopathic Medical Board of California Files Charges Against Bakersfield OB/GYN, Says Consumer Watchdog
The Osteopathic Medical Board of California (OMBC) and the Attorney General's office filed an accusation of charges of gross negligence, and repeated negligent acts against Bakersfield OB/GYN Hans Chunghan Yu D.O. this week. Consumer Watchdog's work...

at 17:00
Voluntary Class 1 Recall Announced for Limited Number of PLANTERS® 4 oz. Honey Roasted Peanuts and 8.75 oz. PLANTERS® Deluxe Lightly Salted Mixed Nuts Distributed to Two Retail Locations in Five States
Hormel Foods Sales, LLC is voluntarily recalling two varieties of PLANTERS® products that were produced at one of its facilities in April. This recall only impacts two retailers in five states. These products are being recalled out of an abundance of...

at 17:00
Richards Packaging Income Fund announces 2024 First Quarter Results
Richards Packaging Income Fund (the "Fund") announced today results for the quarter ended March 31, 2024.      "The first quarter financial performance was in line with the trend set in 2023.  March revenue was very soft driven mainly by weak food...

at 17:00
Viatris to Participate in the BofA Securities 2024 Health Care Conference
Viatris Inc. , a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada on Tuesday, May 14, 2024. Chief Financial Officer Doretta Mistras and...

at 16:58
Yale's Akiko Iwasaki, PhD, named to TIME100 Lists of Most Influential People in the World
TIME has named Yale School of Medicine immunobiologist Dr. Akiko Iwasaki to the 2024 TIME100 Health, the magazine's annual list of the 100 most influential people in global health care. She was also named last week to the TIME100, TIME's list of the...

at 16:56
Facet Replacement Fda Study Garners Best Paper Award At Lumbar Spine Research Society Meeting
Premia Spine, a leader in innovative spinal treatment solutions, today announced that the pioneering study titled "Lumbar Facet Arthroplasty for...

More news about Health...


News published on and distributed by: